Volume 11, Number 6—June 2005
Research
Methicillin-resistant–Staphylococcus aureus Hospitalizations, United States
Matthew J. Kuehnert*, Holly A. Hill*, Benjamin A. Kupronis*, Jerome I. Tokars*, Steven L. Solomon*, and Daniel B. Jernigan*
Table 2
Staphylococcus aureus–related hospitalizations, United States, 1999–2000, by geographic region*
| Region | Discharge diagnosis |
|||
|---|---|---|---|---|
| S. aureus (%) | S. aureus rate† | MR (%) | MRSA rate† | |
| West | 17.4 | 9.04 | 31.4 | 2.84 |
| Northeast | 20.5 | 8.51 | 41.3 | 3.52 |
| Midwest | 22.6 | 9.06 | 43.5 | 3.94 |
| South | 39.5 | 9.58 | 46.5 | 4.45 |
*MR, methicillin resistant; MRSA, methicillin-resistant S. aureus.
†Rate, hospitalizations with S. aureus– or MRSA–related discharge diagnoses per 1,000 discharges.
